Metraipolis › archive › dc_f21fb3875cee

Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:42274623

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42274623
DOI
10.3390/cells15111032
License (as archived)
solo-consultazione
Archived
2026-10-31T18:57:15.532Z
SHA-256 of the archived text
9fd1a5a135881f6ae661b4356f3d903f73ca4a755bd6b628548ff664d11ceb5d
Stable URL of this page
https://metraipolis.com/documento/dc_f21fb3875cee

How to cite

Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:42274623 — Europe PMC (en), https://europepmc.org/article/MED/42274623 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f21fb3875cee (Metraipolis archive dc_f21fb3875cee, sha256 9fd1a5a135881f6ae661b4356f3d903f73ca4a755bd6b628548ff664d11ceb5d)
BibTeX
@misc{dcf21fb3875cee,
  title = {Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma — Europe PMC PMID:42274623},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42274623},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f21fb3875cee; sha256 9fd1a5a135881f6ae661b4356f3d903f73ca4a755bd6b628548ff664d11ceb5d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42274623. Agents can read the archived copy with the MCP tool read_document.